InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by MacDougall Ann L., Director. Director active across 1 companies, notably Opiant Pharmaceuticals, INC.. Aggregated, 6 disclosures have been published. Total volume traded: €32k. The latest transaction was filed on 14 June 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
02,000 shares0
Common Stock
SEC:0001385508-22-000084:0·
€31,5793,000 shares@ €10.526484.8% of flow
Common Stock
SEC:0001385508-22-000057:0·
Ideal exit: 7 Feb 2023 (T+270)
02,000 shares0
Common Stock
SEC:0001385508-21-000086·
02,000 shares0
Common Stock
SEC:0001385508-21-000086:0·
€2,823341 shares@ €8.28100.0% of flow
Common Stock
SEC:0001385508-21-000070·
€2,823341 shares@ €8.287.6% of flow
Common Stock
SEC:0001385508-21-000070:0·
6 of 6 declarations
About MacDougall Ann L.
Ann L. MacDougall is a Board Member at OPIANT PHARMACEUTICALS, INC., a biopharmaceutical company. As a board member, she participates in the strategy and management of the company. Her expertise in the pharmaceutical sector is an asset for Opiant.
